Close Menu

NEW YORK – Quidel reported after the close of the market on Wednesday that its third quarter revenues rose 8 percent year over year, beating Wall Street estimates.

For the three months ended Sept. 30, revenues increased to $126.5 million from $117.4 million in Q3 2018, beating the average analyst expectation of $125.6 million. The increase was driven primarily by growth in the rapid immunoassay business.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Rady Children's Institute for Genomic Medicine and Deloitte are looking into the use of drones to transport samples for testing. 

Direct-to-consumer genetic testing firm 23andMe is laying off about 100 people.

Researchers from Northwestern University examined dust for antibiotic-resistance genes, New Scientist reports. 

In Science this week: researchers present a computational method for predicting cellular differentiation state from single-cell RNA sequencing data, and more.